CurrentBlue Cross Blue Shield - MassachusettsPolicy N/A

Interspinous fixation (fusion) devices

This policy governs coverage and precertification requirements for interspinous fixation (fusion) devices for BCBS Massachusetts members across commercial and Medicare lines, including use with interbody fusion or as stand-alone decompression.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyInterspinous fixation (fusion) devices

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionObtain precertification/preauthorization for services described in this policy.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

InvestigationalPolicy stance

510(k) devicesDevices listed

RequiredPrecertification

C1821HCPCS

Coverage Determination and Rationale

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Policy stance: Interspinous fixation (fusion) devices are INVESTIGATIONAL for any indication, including use in combination with interbody fusion or as a stand-alone procedure for decompression in individuals with spinal stenosis.

Policy lists specific FDA 510(k)-cleared devices but maintains an investigational coverage stance.

Use of an interspinous fixation device as a stand-alone procedure is considered off-label and investigational. The policy states these devices are intended as adjuncts to interbody fusion and that stand-alone use is not within the cleared indications. Additionally, outpatient procedures described in this policy are noted as not covered for multiple product lines, and precertification/preauthorization is required for services described in the policy.

The evidence is insufficient to determine whether interspinous fixation devices improve net health outcomes when used in combination with interbody fusion or when used as a stand-alone procedure for decompression in patients with spinal stenosis or spondylolisthesis. Randomized trials that exist are small, have methodological limitations, and provide unclear comparative safety data (for example, risks such as spinous process fracture), so further well-designed randomized trials with longer follow-up are needed to establish effectiveness.

Provider Requirements and Billing Guidance

Prior Authorization

Prior Authorization Required

Precertification/Preauthorization is required for services described in this policy when the procedure is performed inpatient. For outpatient procedures, prior authorization requirements vary by product: Commercial Managed Care (HMO and POS) — outpatient: This is not a covered service; Commercial PPO and Indemnity — outpatient: This is not a covered service; Medicare HMO Blues — outpatient: This is not a covered service; Medicare PPO Blues — outpatient: This is not a covered service.

Billing Rule

Coding and Reporting

Providers should report all services using the most up-to-date industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable. Inclusion or exclusion of a specific code in this policy does not determine member coverage or guarantee payment. The codes listed in the policy are for informational purposes and are not an all-inclusive list. Providers must follow payer billing guidelines and submit supporting documentation as appropriate.

Denial Risk

Coverage / Denial Triggers

Outpatient procedures described in this policy are not covered for Commercial PPO/Indemnity and Medicare lines as noted above; services performed outpatient for these products are considered not a covered service and may be denied if billed. Verify member benefits and coverage prior to scheduling procedures.

Step Therapy

Step therapy requirements are not specified in this policy.

Clinical Background

Interspinous fixation devices are posterior, nonpedicle supplemental fixation implants intended to be attached to the spinous processes to stabilize a single lumbar level (L1–S1) and promote fusion when used as an adjunct to an interbody cage. They were developed as an alternative to traditional pedicle screw–rod constructs; contemporary designs are rigid implants intended to provide supplemental stabilization during interbody fusion but may have limitations in controlling axial rotation and lateral bending and can be associated with complications such as spinous process fracture and focal kyphosis.

Key Definitions

Interspinous fixation device — definition as posterior, nonpedicle supplemental fixation device for single-level adjunct to fusion

DefinitionA posterior, nonpedicle supplemental fixation device intended for use with an interbody cage as an adjunct to fusion at a single lumbar level (L1–S1), attached to the spinous processes to achieve stabilization and promote fusion in patients with degenerative disc disease (up to Grade 1 spondylolisthesis).

Intended useDesigned as a supplemental fixation to be used in combination with interbody fusion (not intended for stand-alone use).

Attachment siteAffixed to the spinous processes to provide stabilization for fusion procedures.

Scope/levelsFor single-level lumbar spine application (L1–S1).

Off‑label/stand‑alone useUse of an interspinous fixation device as a stand-alone procedure (e.g., as a spacer for decompression) is considered off-label and investigational and carries risks such as spinous process fracture and focal kyphosis.